
GC36424
Larotaxel
Also known as [(1S,2S,3R,4S,7R,9S,11R,13R,16S)-4,13-diacetyloxy-1-hydroxy-16-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-15,18,18-trimethyl-12-oxo-6-oxapentacyclo[12.3.1.03,11.04,7.09,11]octadec-14-en-2-yl] benzoate
Larotaxel (XRP9881) is a taxane analogue with preclinical activity against taxane-resistant breast cancer· Larotaxel (XRP9881) exerts its cytotoxic effect by promoting tubulin assembly and stabilizing microtubules, ultimately leading to cell death by apoptosis· It presents the ability to cross the blood brain barrier and has a much lower affinity for P-glycoprotein 1 than Docetaxel
- CAS number
- 156294-36-9
- Molecular weight
- 831.9
- Formula
- C45H53NO14
- Solubility
- DMSO: ≥ 50 mg/mL (60·10 mM)
- InChIKey
- DXOJIXGRFSHVKA-BZVZGCBYSA-N
- Catalogue number
- GC36424
- Brand
- GLPBIO
Computed properties PubChem CID 6918260 · XLogP 2.7 · TPSA 210 Ų · H-bond donors 3
- XLogP
- 2.7
- TPSA
- 210 Ų
- H-bond donors
- 3
- H-bond acceptors
- 14
- Rotatable bonds
- 15
- Heavy atoms
- 60
SMILES CC1=C2[C@H](C(=O)[C@]34C[C@H]3C[C@@H]5[C@]([C@H]4[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C6=CC=CC=C6)NC(=O)OC(C)(C)C)O)O)OC(=O)C7=CC=CC=C7)(CO5)OC(=O)C)OC(=O)C
Computed descriptors from PubChem (CID 6918260), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il